Vetoquinol
Company dedicated to global animal health concentrating on livestock, poultry and companion animals.
Launch date
Employees
Market cap
$1.2b
Enterprise valuation
$1.1b (Public information from Sep 2024)
Share price
€82.8 VETO.PA
Company register number 676250111
Paris Île-de-France (HQ)
Financials
Estimates*
| EUR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 427m | 521m | 540m | 529m | 551m | 577m | 600m |
| % growth | 8 % | 22 % | 4 % | (2 %) | 4 % | 5 % | 4 % |
| EBITDA | 83.2m | 120m | 106m | 116m | 110m | 119m | 123m |
| % EBITDA margin | 19 % | 23 % | 20 % | 22 % | 20 % | 21 % | 21 % |
| Profit | 19.2m | 62.9m | 48.0m | 55.6m | 56.5m | 61.4m | 64.3m |
| % profit margin | 4 % | 12 % | 9 % | 10 % | 10 % | 11 % | 11 % |
| EV / revenue | 2.3x | 2.9x | 1.8x | 2.0x | 1.7x | 1.6x | 1.4x |
| EV / EBITDA | 11.7x | 12.6x | 9.1x | 9.3x | 8.7x | 7.6x | 6.8x |
| R&D budget | 3.1m | 2.9m | 2.8m | 1.8m | - | - | - |
| R&D % of revenue | 1 % | 1 % | 1 % | - | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Growth Equity VC | ||
| N/A | N/A | IPO | |
$140m | Acquisition | ||
| Total Funding | - | ||
Related Content
Recent News about Vetoquinol
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.